Pioneering rheumatoid arthritis treatment: Magnesium ion-mediated natural multi-component hydrogel synergistically regulates macrophage polarization, pannus formation, and bone regeneration
(
), Penglong Wang1 ()Graphical Abstract
Abstract
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that affects millions of people worldwide. Current therapeutic drugs for RA are often limited by poor solubility, unresponsive to monotherapy, low bioavailability, and severe side effects. To address these challenges, we developed a pH-responsive, biodegradable, and multifunctional oral hydrogel delivery system (GTPM Gel) based on the major active ingredients (glycyrrhizic acid (GA), total alkaloids of FZ (TAC), pseudoephedrine (PE), Mg2+) from Mahuang Fuzi decoction for the treatment of RA in clinic. In this system, all four components synergistically contributed to gel formation and pharmacodynamics, making each component indispensable. Notably, Mg2+ in GTPM Gel promoted the gelation of GA via coordination bonds while exhibiting anti-inflammatory properties and facilitating osteochondral regeneration. Moreover, GTPM Gel enhanced the solubility of TAC and reduced its toxicity, leading to improved anti-RA effects. In vitro and In vivo studies demonstrated that GTPM Gel effectively inhibited the polarization of inflammatory macrophages, reduced pannus formation, and inhibited bone and cartilage erosion by downregulating the PI3K/AKT/NF-κB signaling pathway. This study suggested that the magnesium ion-mediated natural multi-component hydrogel, with its remarkable efficacy and biocompatibility, holds promise as a potential therapeutic candidate for RA treatment.
Keywords
Electronic Supplementary Material
References
Zhou, S. Y.; Zou, H. Y.; Chen, G. Y.; Huang, G. L. Synthesis and biological activities of chemical drugs for the treatment of rheumatoid arthritis. Top. Curr. Chem. 2019, 377, 28.
Jing, W. Y.; Liu, C.; Su, C. H.; Liu, L. M.; Chen, P.; Li, X. J.; Zhang, X. H.; Yuan, B.; Wang, H. D.; Du, X. Z. Role of reactive oxygen species and mitochondrial damage in rheumatoid arthritis and targeted drugs. Front. Immunol. 2023, 14, 1107670.
Quan, L. D.; Thiele, G. M.; Tian, J.; Wang, D. The development of novel therapies for rheumatoid arthritis. Expert Opin. Ther. Pat. 2008, 18, 723–738.
Sunzini, F.; Schrepf, A.; Clauw, D. J.; Basu, N. The biology of pain: Through the rheumatology lens. Arthritis Rheumatol. 2023, 75, 650–660.
Marrie, R. A.; Bernstein, C. N. Psychiatric comorbidity in immune-mediated inflammatory diseases. World Psychiatry 2021, 20, 298–299.
Jia, N.; Gao, Y. Z.; Li, M.; Liang, Y.; Li, Y. W.; Lin, Y. Z.; Huang, S. Q.; Lin, Q.; Sun, X.; He, Q. et al. Metabolic reprogramming of proinflammatory macrophages by target delivered roburic acid effectively ameliorates rheumatoid arthritis symptoms. Signal Transduct. Target. Ther. 2023, 8, 280.
Fosnocht, D. E.; Hollifield, M. B.; Swanson, E. R. Patient preference for route of pain medication delivery. J. Emerg. Med. 2004, 26, 7–11.
Chapa-Villarreal, F. A.; Stephens, M.; Pavlicin, R.; Beussman, M.; Peppas, N. A. Therapeutic delivery systems for rheumatoid arthritis based on hydrogel carriers. Adv. Drug Delivery Rev. 2024, 208, 115300.
Nooreen, R.; Nene, S.; Jain, H.; Prasannanjaneyulu, V.; Chitlangya, P.; Otavi, S.; Khatri, D. K.; Raghuvanshi, R. S.; Singh, S. B.; Srivastava, S. Polymer nanotherapeutics: A versatile platform for effective rheumatoid arthritis therapy. J. Controlled Release 2022, 348, 397–419.
Zhang, Y.; Wang, X. Y.; Ding, Z. H.; Lin, N.; Zhang, Y. Q. Enhanced efficacy with reduced toxicity of tripterygium glycoside tablet by compatibility with total glucosides of paeony for rheumatoid arthritis therapy. Biomed. Pharmacother. 2023, 166, 115417.
Kesharwani, P.; Bisht, A.; Alexander, A.; Dave, V.; Sharma, S. Biomedical applications of hydrogels in drug delivery system: An update. J. Drug Delivery Sci. Technol. 2021, 66, 102914.
Hua, S. S. Advances in oral drug delivery for regional targeting in the gastrointestinal tract - influence of physiological, pathophysiological and pharmaceutical factors. Front. Pharmacol. 2020, 11, 524.
Carrillo-Conde, B. R.; Brewer, E.; Lowman, A.; Peppas, N. A. Complexation hydrogels as oral delivery vehicles of therapeutic antibodies: An in vitro and ex vivo evaluation of antibody stability and bioactivity. Ind. Eng. Chem. Res. 2015, 54, 10197–10205.
Shi. Y. L.; Liu, Z. M.; Yang, Y. X.; Xu, X. J.; Li, Y.; Li, T. Design of poly(mPEGMA-co-MAA) hydrogel-based mPEG-b-PCL nanoparticles for oral meloxicam delivery. Mater. Sci. Eng. C 2017, 76, 975–984.
Mahmood, A.; Erum, A.; Mumtaz, S.; Tulain, U. R.; Malik, N. S.; Alqahtani, M. S. Preliminary investigation of Linum usitatissimum mucilage-based hydrogel as possible substitute to synthetic polymer-based hydrogels for sustained release oral drug delivery. Gels 2022, 8, 170.
Wang, B. L.; Yuan, T. T.; Zha, L. Q.; Liu, Y. X.; Chen, W. D.; Zhang, C. Y.; Bao, Y. M.; Dong, Q. N. Oral delivery of gambogenic acid by functional polydopamine nanoparticles for targeted tumor therapy. Mol. Pharm. 2021, 18, 1470–1479.
Wang, T. R.; Luo, Y. C. Fabrication strategies and supramolecular interactions of polymer-lipid complex nanoparticles as oral delivery systems. Nano Res. 2021, 14, 4487–4501.
Pi, W. M.; Wu, L. Y.; Lu, J. H.; Lin, X. Y.; Huang, X. M.; Wang, Z. J.; Yuan, Z. H.; Qiu, H. L.; Zhang, J. L.; Lei, H. M. et al. A metal ions-mediated natural small molecules carrier-free injectable hydrogel achieving laser-mediated photo-Fenton-like anticancer therapy by synergy apoptosis/cuproptosis/anti-inflammation. Bioact. Mater. 2023, 29, 98–115.
Lu, J. H.; Zhao, H. Q.; Wang, Z. J.; Lin, X. Y.; Pi, W. M.; Zhang, X.; Yang, L. P.; Yao, S. C.; Zhang, Y. Z.; Huang, X. M. et al. Glucose epimerization-modulated phytochemicals constructing carrier-free hydrogel for regulation of macrophage phenotype to promote wound healing. Adv. Funct. Mater. 2024, 34, 2314089.
Yang, L. P.; Zhang, X.; Wang, Z. J.; Lin, X. Y.; Zhang, Y. Z.; Lu, J. H.; Wu, L. Y.; Yao, S. C.; Jing, W. G.; Huang, X. M. et al. Decoction regulating phytochemicals’ micromorphology changes and anti-inflammation activity enhancements originated from herb medicine supermolecules. Chin. Med. 2024, 19, 19.
Tykarska, E.; Sobiak, S.; Gdaniec, M. Supramolecular organization of neutral and ionic forms of pharmaceutically relevant glycyrrhizic acid-amphiphile self-assembly and inclusion of small drug molecules. Cryst. Growth Des. 2012, 12, 2133–2137.
Matsuoka, K.; Miyajima, R.; Ishida, Y.; Karasawa, S.; Yoshimura, T. Aggregate formation of glycyrrhizic acid. Colloids Surf. A: Physicochem. Eng. Asp. 2016, 500, 112–117.
Li, S.; Guo, J. S.; Tian, Z. H.; Chen, J.; Gou, G. J.; Niu, Y.; Li, L.; Yang, J. H. Piperine-loaded glycyrrhizic acid- and PLGA-based nanoparticles modified with transferrin for antitumor. AAPS PharmSciTech 2021, 22, 239.
Zeng, X. Z.; He, L. G.; Wang, S.; Wang, K.; Zhang, Y. Y.; Tao, L.; Li, X. J.; Liu, S. W. Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression. Acta Pharmacol. Sin. 2016, 37, 255–263.
Zheng, Y. J.; Yang, Y.; Li, Y. H.; Xu, L. M.; Wang, Y.; Guo, Z. Y.; Song, H. Y.; Yang, M. Y.; Luo, B. E.; Zheng, A. X. et al. Ephedrine hydrochloride inhibits PGN-induced inflammatory responses by promoting IL-10 production and decreasing proinflammatory cytokine secretion via the PI3K/Akt/GSK3β pathway. Cell. Mol. Immunol. 2013, 10, 330–337.
Wang, W.; Luo, M.; Fu, Y. J.; Wang, S. Efferth, T. ; Zu, Y. G. Glycyrrhizic acid nanoparticles inhibit LPS-induced inflammatory mediators in 264.7 mouse macrophages compared with unprocessed glycyrrhizic acid. Int. J. Nanomedicine 2013, 8, 1377–1383.
Hu, T.; Xu, H. T.; Wang, C. Y.; Qin, H.; An, Z. Q. Magnesium enhances the chondrogenic differentiation of mesenchymal stem cells by inhibiting activated macrophage-induced inflammation. Sci. Rep. 2018, 8, 3406.
Fu, H.; Guo, Y. D.; Fang, W. M.; Wang, J. X.; Hu, P.; Shi, J. L. Anti-acidification and immune regulation by nano-ceria-loaded Mg–Al layered double hydroxide for rheumatoid arthritis therapy. Adv. Sci. 2024, 11, 2307094.
Xia, T.; Zhu, Y. T.; Li, K. Q.; Hao, K.; Chai, Y. Q.; Jiang, H. Y.; Lou, C.; Yu, J. C.; Yang, W.; Wang, J. L. et al. Microneedles loaded with cerium-manganese oxide nanoparticles for targeting macrophages in the treatment of rheumatoid arthritis. J. Nanobiotechnol. 2024, 22, 103.
Ding, Q.; Hu, W.; Wang, R.; Yang, Q. Y.; Zhu, M. L.; Li, M.; Cai, J. H.; Rose, P.; Mao, J. C.; Zhu, Y. Z. Signaling pathways in rheumatoid arthritis: Implications for targeted therapy. Signal Transduct. Target. Ther. 2023, 8, 68.
Pan, T. T.; Sun, S. Q.; Chen, Y.; Tian, R.; Chen, E. Z.; Tan, R. M.; Wang, X. L.; Liu, Z. J.; Liu, J. L.; Qu, H. P. Immune effects of PI3K/Akt/HIF-1α-regulated glycolysis in polymorphonuclear neutrophils during sepsis. Crit. Care 2022, 26, 29.
Li, N.; Sun, W. J.; Zhou, X.; Gong, H.; Chen, Y. Q.; Chen, D. F.; Xiang, F. Dihydroartemisinin protects against dextran sulfate sodium-induced colitis in mice through inhibiting the PI3K/AKT and NF- κB signaling pathways. Biomed. Res. Int. 2019, 2019, 1415809.
Ma, S. D.; Gu, S. N.; Zhang, J. W.; Qi, W. Z.; Lin, Z. W.; Zhai, W. C.; Zhan, J.; Li, Q.; Cai, Y. B.; Lu, Y. Robust drug bioavailability and safety for rheumatoid arthritis therapy using D-amino acids-based supramolecular hydrogels. Mater. Today Bio 2022, 15, 100296.
Wang, L.; Li, P. F.; Zhou, Y.; Gu, R. J.; Lu, G.; Zhang, C. B. Magnoflorine ameliorates collagen-induced arthritis by suppressing the inflammation response via the NF-κB/MAPK signaling pathways. J. Inflamm. Res. 2023, 16, 2271–2296.
Jie, S. S.; Sun, H. J.; Liu, J. X.; Gao, Y.; Bai, D.; Zhu, L. L.; Zhao, H. Y.; Zeng, H.; Ma, Y. L. Simiao Yong’an decoction ameliorates murine collagen-induced arthritis by modulating neutrophil activities: An in vitro and in vivo study. J. Ethnopharmacol. 2023, 305, 116119.
Hosseinzadeh, H.; Nassiri-Asl, M. Pharmacological effects of Glycyrrhiza spp. and its bioactive constituents: Update and review. Phytother. Res. 2015, 29, 1868–1886.
Gai, W. W.; Hao, X. F.; Zhao, J. D.; Wang, L. N.; Liu, J. H.; Jiang, H. X.; Jin, H.; Liu, G. L.; Feng, Y. K. Delivery of benzoylaconitine using biodegradable nanoparticles to suppress inflammation via regulating NF-κB signaling. Colloids Surf. B: Biointerfaces 2020, 191, 110980.
Li, Z.; Yuan, J.; Dai, Y.; Xia, Y. F. Integration of serum pharmacochemistry and metabolomics to reveal the underlying mechanism of shaoyao-gancao-fuzi decoction to ameliorate rheumatoid arthritis. J. Ethnopharmacol. 2024, 326, 117910.
Abraham, M. J.; Murtola, T.; Schulz, R.; Páll, S.; Smith, J. C.; Hess, B.; Lindahl, E. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 2015, 1–2, 19–25
Lu, T.; Tan, H. W.; Lee, D.; Chen, G. J.; Jia, Z. C. New insights into the activation of Escherichia coli tyrosine kinase revealed by molecular dynamics simulation and biochemical analysis. Biochemistry 2009, 48, 7986–7995.
Neese, F. Software update: The ORCA program system-Version 5.0. WIREs Comput. Mol. Sci. 2022, 12, e1606.
Lu, T.; Chen, Q. X. Independent gradient model based on Hirshfeld partition: A new method for visual study of interactions in chemical systems. J. Comput. Chem. 2022, 43, 539–555.
Prasad, P.; Gupta, A.; Sasmal, P. K. Aggregation-induced emission active metal complexes: A promising strategy to tackle bacterial infections. Chem. Commun. 2021, 57, 174–186.
Brady, M.; Shchepetkina, V. I.; González-Recio, I.; Martínez-Chantar, M. L.; Buccella, D. Ratiometric fluorescent sensors illuminate cellular magnesium imbalance in a model of acetaminophen-induced liver injury. J. Am. Chem. Soc. 2023, 145, 21841–21850.
Deng, Z. H.; Yang, C.; Xiang, T. W.; Dou, C.; Sun, D.; Dai, Q. J.; Ling, Z. G.; Xu, J. Z.; Luo, F.; Chen, Y. Q. Gold nanoparticles exhibit anti-osteoarthritic effects via modulating interaction of the “microbiota-gut-joint” axis. J. Nanobiotechnol. 2024, 22, 157.
Huang, X.; Zhang, W. Y. Macrophage membrane-camouflaged biomimetic nanovesicles for targeted treatment of arthritis. Ageing Res. Rev. 2024, 95, 102241.
Choi, B.; Lee, C.; Yu, J. W. Distinctive role of inflammation in tissue repair and regeneration. Arch. Pharm. Res. 2023, 46, 78–89.
Ye, J. C.; Xie, C.; Wang, C. L.; Huang, J. Y.; Yin, Z.; Heng, B. C.; Chen, X.; Shen, W. L. Promoting musculoskeletal system soft tissue regeneration by biomaterial-mediated modulation of macrophage polarization. Bioact. Mater. 2021, 6, 4096–4109.
Fu, M.; Yang, C. S.; Sun, G. X. Recent advances in immunomodulatory hydrogels biomaterials for bone tissue regeneration. Mol. Immunol. 2023, 163, 48–62.
Liu, P.; Peng, J.; Han, G. H.; Ding, X.; Wei, S.; Gao, G.; Huang, K.; Chang, F.; Wang, Y. Role of macrophages in peripheral nerve injury and repair. Neural Regen. Res. 2019, 14, 1335–1342.
Huang, R.; Wang, X.; Zhou, Y. H.; Xiao, Y. RANKL-induced M1 macrophages are involved in bone formation. Bone Res. 2017, 5, 17019.
Shapouri-Moghaddam, A.; Mohammadian, S.; Vazini, H.; Taghadosi, M.; Esmaeili, S. A.; Mardani, F.; Seifi, B.; Mohammadi, A.; Afshari, J. T.; Sahebkar, A. Macrophage plasticity, polarization, and function in health and disease. J. Cell. Physiol. 2018, 233, 6425–6440.
Shang, W. C.; Sun, Q. W.; Zhang, C. X.; Liu, H. M.; Yang, Y.; Liu, Y.; Gao, W. H.; Shen, W.; Yin, D. K. Drug in therapeutic polymer: Sinomenine-loaded oxidation-responsive polymeric nanoparticles for rheumatoid arthritis treatment. ACS Appl. Mater. Interfaces 2023, 15, 47552–47565.
Bai, D.; Vogt, P. Akt induces NF-κB activation by a phosphorylation cascade. Cancer Res. 2008, 68, 2423.
Gang, F. L.; Zhang, Q.; Jiang, L.; Xiao, Y.; Xu, N.; Wang, Y. L.; Xiao, Y.; Li, A. J.; Liu, Z. Y.; Liu, B. et al. Thermochemotherapy meets tissue engineering for rheumatoid arthritis treatment. Adv. Funct. Mater. 2021, 31, 2104131.
Wan, C. F.; Xu, Y. L.; Cen, B. Y.; Xia, Y. C.; Yao, L.; Zheng, Y. J.; Zhao, J. Y.; He, S.; Chen, Y. J. Neuregulin1-ErbB4 signaling in spinal cord participates in electroacupuncture analgesia in inflammatory pain. Front. Neurosci. 2021, 15, 636348.
Muley, M. M.; Krustev, E.; McDougall, J. J. Preclinical assessment of inflammatory pain. CNS Neurosci. Ther. 2016, 22, 88–101.
Yuan, S. S.; Chai, Y. Q.; Xu, J. H.; Wang, Y. C.; Jiang, L. H.; Lu, N.; Jiang, H. Y.; Wang, J. L.; Pan, X. Y.; Deng, J. J. Engineering efferocytosis-mimicking nanovesicles to regulate joint anti-inflammation and peripheral immunosuppression for rheumatoid arthritis therapy. Adv. Sci. 2024, 11, 2404198.
Davies, L. C.; Jenkins, S. J.; Allen, J. E.; Taylor, P. R. Tissue-resident macrophages. Nat. Immunol. 2013, 14, 986–995.
Alivernini, S.; MacDonald, L.; Elmesmari, A.; Finlay, S.; Tolusso, B.; Gigante, M. R.; Petricca, L.; Di Mario, C.; Bui, L.; Perniola, S. et al. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nat. Med. 2020, 26, 1295–1306.
Zhang, M.; Zhang, R. S.; Dong, Y. X.; Liu, J. J.; Gao, Z.; Zhou, X. Y.; Cao, J. Oxygen supplementation liposomes for rheumatoid arthritis treatment via synergistic phototherapy and repolarization of M1-to-M2 macrophages. Chem. Eng. J. 2023, 459, 141484.
Tardito, S.; Martinelli, G.; Soldano, S.; Paolino, S.; Pacini, G.; Patane, M.; Alessandri, E.; Smith, V.; Cutolo, M. Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review. Autoimmun. Rev. 2019, 18, 102397.
Zhang, W. J.; Chen, Y.; Liu, Q.; Zhou, M.; Wang, K.; Wang, Y. Z.; Nie, J. S.; Gui, S. Y.; Peng, D. Y.; He, Z. G. et al. Emerging nanotherapeutics alleviating rheumatoid arthritis by readjusting the seeds and soils. J. Controlled Release 2022, 345, 851–879.
Aggarwal, A.; Panda, S.; Misra, R. Effect of etanercept on matrix metalloproteinases and angiogenic vascular endothelial growth factor: A time kinetic study. Ann. Rheum. Dis. 2004, 63, 891–892.
Tong, P. J.; Wu, C. L.; Wang, X. F.; Hu, H. Z.; Jin, H. T.; Li, C. Y.; Zhu, Y.; Shan, L. T.; Xiao, L. W. Development and assessment of a complete-detoxication strategy for Fuzi (lateral root of Aconitum carmichaeli) and its application in rheumatoid arthritis therapy. J. Ethnopharmacol. 2013, 146, 562–571.
Feng, W. W.; Liu, J.; Zhang, D. D.; Tan, Y. Z.; Cheng, H.; Peng, C. Revealing the efficacy-toxicity relationship of Fuzi in treating rheumatoid arthritis by systems pharmacology. Sci. Rep. 2021, 11, 23083.
京公网安备11010802044758号